Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
43 participants
INTERVENTIONAL
2015-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Gastrointestinal Tolerance Evaluation of an Infant Formula
NCT03307122
Tolerance of Healthy Infants Fed Infant Formulas
NCT02401217
Study in Unsettled Infants Experiencing Feeding Intolerance
NCT02021058
Tolerance of Healthy Term Infants Fed Infant Formulas
NCT00705562
Feeding Trial in Pediatric Patients
NCT01469117
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Formula 1
infant formula
infant formula
infant formulas
Formula 2
infant formula
infant formula
infant formulas
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
infant formula
infant formulas
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Full-term (\> 37 weeks gestation)
* 0-2 months (birth-56 days) of age on enrollment
* Infant exclusively formula-fed for at least 2 days prior to enrollment
* Having obtained his/her legal representative's informed consent
Exclusion Criteria
* Congenital illness or malformation
* Significant prenatal and/or postnatal disease
* Currently participating in another clinical study
2 Months
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Société des Produits Nestlé (SPN)
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rich Litov, PhD
Role: PRINCIPAL_INVESTIGATOR
Pedia Research
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pedia Research
Owensboro, Kentucky, United States
Tanner Clinic
Layton, Utah, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
14.32.US.INF
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.